Search results
Tasuku Honjo (本庶 佑, Honjo Tasuku?, Kioto, 27 de enero de 1942) es un inmunólogo japonés, conocido por haber identificado la Proteína 1 de la muerte celular programada . [1]
Learn about the life and work of Tasuku Honjo, who discovered the protein PD-1 and its role in immunotherapy. Read his biography, from his childhood in wartime Japan to his breakthrough discoveries in molecular biology and cancer research.
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).
Tasuku Honjo. The Nobel Prize in Physiology or Medicine 2018. Born: 27 January 1942, Kyoto, Japan. Affiliation at the time of the award: Kyoto University, Kyoto, Japan. Prize motivation: “for their discovery of cancer therapy by inhibition of negative immune regulation”. Prize share: 1/2.
1 de oct. de 2018 · La Asamblea Nobel del Instituto Karolinska de Estocolmo les otorgó el Nobel de Medicina al estadounidense James P. Allison y el japonés Tasuku Honjo por haber descubierto una terapia contra el...
Tasuku Honjo is a distinguished professor and deputy director-general of KUIAS, and a Nobel laureate in medicine for his discovery of PD-1. He has also made significant contributions to molecular immunology, class switch recombination, and cancer immunotherapy.
1 de oct. de 2018 · Tasuku Honjo and James Allison share the 2018 Nobel Prize in Physiology or Medicine for discovering how to unleash the immune system to attack cancer cells. They studied different proteins that act as brakes on T cells, leading to the development of drugs that have extended survival in some patients.
